RecruitingNCT04369209

A Registered Cohort Study on FSHD1

A Registered Observational Cohort Study of Facioscapulohumeral Muscular Dystrophy Type 1


Sponsor

Ning Wang, MD., PhD.

Enrollment

1,000 participants

Start Date

Jan 1, 2001

Study Type

OBSERVATIONAL

Conditions

Summary

The data to be collected is intended to help healthcare providers make important medical and financial decisions concerning FSHD1, through an enhanced understanding of the prevalence, progression and natural history of FSHD1.


Eligibility

Inclusion Criteria3

  • Male or female subjects of all ages at baseline
  • Subjects, with or without symptoms, with FSHD1 genetic confirmation through PFGE-based Southern blotting
  • Unrelated healthy controls

Exclusion Criteria3

  • Decline to participate
  • Other neuromuscular disease (such as Limb-girdle muscular dystrophy or Myotonic dystrophy)
  • Serious systemic illness (such as heart, liver, kidney disease or major mental illness)

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

First Affiliated Hospital of Fujian Medical University

Fuzhou, Fujian, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04369209